For trauma patients with exsanguinating torso hemorrhage, resuscitative endovascular balloon occlusion of the aorta (REBOA) did not reduce mortality, and may have increased 90-day mortality, when ...

Resuscitative endovascular balloon occlusion of the aorta (REBOA) is an emergent intervention designed to temporarily control life-threatening haemorrhage in patients with non-compressible torso ...

For patients with nontraumatic, out-of-hospital cardiac arrest (OHCA), evolving technology in the form of resuscitative endovascular balloon occlusion of the aorta, as well as expanded use of ...

Two newer approaches to management of major hemorrhage missed the mark in randomized clinical trials published in a special transfusion-related issue of JAMA. In the CRYOSTAT-2 trial, adding early, ...

Dr. Chance Spalding uses the REBOA technique to help victims of car crashes or shootings at Grant Medical Center. A small balloon could be one of the best bets for Columbus doctors to save gunshot ...

San Antonio, TX ., Pryor Medical Devices (The REBOA Company TM), today announced it has received FDA 510(k) clearance for the sale and distribution of its ER-REBOA TM catheter. REBOA (Resuscitative ...

MADIGAN ARMY MEDICAL CENTER, Joint Base Lewis-McChord, Wash. -- Surgical research at Madigan Army Medical Center directly contributed to new trauma medical procedures to address the top cause of ...

LONDON, Ontario, June 29, 2021 (GLOBE NEWSWIRE) -- Front Line Medical Technologies, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its COBRA-OS™ (Control of Bleeding ...

A new technique used to control severe bleeding in injured patients has been found to increase the risk of death, according to new research from the University of Aberdeen, in Scotland, which was led ...

LONDON, Ontario – Sept. 10, 2021 – Excessive blood loss is one of the leading causes of death in trauma patients, and trauma is the fourth leading cause of death overall for all ages. That’s where ...

BOERNE, Texas, Jan. 7, 2025 /PRNewswire/ -- Prytime Medical, The REBOA Company™, proudly announces the first civilian use of its pREBOA-PRO™ catheter in the European Union, following the device's ...